MusclePharm Corporation Lease, Cost
MusclePharm Corporation reported Lease, Cost of $451.00 thousand for the 12-month period ending 2021-12-31, per its 10-K/A filed 2022-05-04.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LeaseCost · last filed 2022-05-04
- MusclePharm Corporation lease, cost for the quarter ending 2021-03-31 was $13.00K, a 96.14% decline year-over-year.
- MusclePharm Corporation lease, cost for the quarter ending 2020-12-31 was $24.00K, a 89.04% decline year-over-year.
- MusclePharm Corporation lease, cost for the quarter ending 2020-09-30 was $218.00K, a 21.58% decline year-over-year.
- MusclePharm Corporation lease, cost for the quarter ending 2020-06-30 was $288.00K, a 8.68% increase year-over-year.
- MusclePharm Corporation lease, cost for fiscal 2021 was $451.00K, a 42.40% decline from fiscal 2020.
- MusclePharm Corporation lease, cost for fiscal 2020 was $783.00K, a 22.09% decline from fiscal 2019.
- MusclePharm Corporation lease, cost for fiscal 2019 was $1.00M.
| Period end | Lease, Cost 3 month | Lease, Cost 6 month | Lease, Cost 9 month | Lease, Cost 12 month |
|---|---|---|---|---|
| 2021-12-31 | $451.00K 10-K/A · filed 2022-05-04 | |||
| 2021-03-31 | $13.00K 10-Q · filed 2021-05-24 | $37.00K derived: sum of 2 quarters · filed 2022-05-04 | $255.00K derived: sum of 3 quarters · filed 2022-05-04 | $543.00K derived: sum of 4 quarters · filed 2022-05-04 |
| 2020-12-31 | $24.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-05-04 | $242.00K derived: sum of 2 quarters · filed 2022-05-04 | $530.00K derived: sum of 3 quarters · filed 2022-05-04 | $783.00K 10-K/A · filed 2022-05-04 |
| 2020-09-30 | $218.00K 10-Q · filed 2020-11-24 | $506.00K derived: sum of 2 quarters · filed 2020-11-24 | $759.00K 10-Q · filed 2020-11-24 | $1.06M derived: sum of 4 quarters · filed 2021-05-24 |
| 2020-06-30 | $288.00K 10-Q · filed 2020-11-24 | $623.00K 10-Q · filed 2020-11-24 | $844.00K derived: sum of 3 quarters · filed 2021-05-24 | $1.12M derived: sum of 4 quarters · filed 2021-05-24 |
| 2020-03-31 | $337.00K 10-Q · filed 2021-05-24 | $556.00K derived: sum of 2 quarters · filed 2021-05-24 | $834.00K derived: sum of 3 quarters · filed 2021-05-24 | $1.10M derived: sum of 4 quarters · filed 2021-05-24 |
| 2019-12-31 | $219.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | $497.00K derived: sum of 2 quarters · filed 2021-03-29 | $762.00K derived: sum of 3 quarters · filed 2021-03-29 | $1.00M 10-K · filed 2021-03-29 |
| 2019-09-30 | $278.00K 10-Q · filed 2020-11-24 | $543.00K derived: sum of 2 quarters · filed 2020-11-24 | $786.00K 10-Q · filed 2020-11-24 | |
| 2019-06-30 | $265.00K 10-Q · filed 2020-11-24 | $507.00K 10-Q · filed 2020-11-24 | ||
| 2019-03-31 | $243.00K 10-Q · filed 2020-11-24 |